Search results
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Zacks via Yahoo Finance· 3 days agoIn the latest trading session, Novavax (NVAX) closed at $4.33, marking a +0.93% move from the...
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
Motley Fool via Yahoo Finance· 4 days agoOther times, some corporations lag the market for good reasons: Their businesses and prospects look...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 1 day agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 21 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Q1 2024 Enovix Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoBefore we continue, let me kindly remind you that we released our first quarter 2024 shareholder letter after the market close today is available on our website at ir dot novavax< ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 hours agoBrooklyn, New York, May 03, 2024 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the global biomaterial-based vaccines market is analyzed to grow at a CAGR of 17.7% during the forecast period
What's in the Cards for Amgen (AMGN) This Earnings Season?
Zacks via Yahoo Finance· 4 days agoVolume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
The path to a better tuberculosis vaccine runs through Montana
Medical Xpress· 4 days agoA team of Montana researchers is playing a key role in the development of a more effective vaccine...
ESCMID 2024: Cutting-edge vaccines in development for a healthier tomorrow
Clinical Trials Arena via Yahoo Finance· 2 days agoThe R21/Matrix-M vaccine, developed by Oxford University and the Serum Institute of India,...
